2nd Quarter - Report
K&L GATES, LLP for PEAR THERAPEUTICS, INC.
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.7051, S.3791, Access to Prescription Digital Therapeutics Act of 2022; Federal policy related to prescription digital therapeutics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SCOTT ALIFERIS | — |
| BART GORDON | — |
| VICTORIA K. HAMSCHO New | — |
| SEAN MCGLYNN New | Staff Asst/Asst to Chief of Staff, Senator Mikulski |
| DENNIS POTTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.